Literature DB >> 8120369

Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.

R Ettinger1, J K Wang, P Bossu, K Papas, C L Sidman, A K Abbas, A Marshak-Rothstein.   

Abstract

Homozygosity for either of the autosomal recessive mutations, lpr or gld, confers an autoimmune syndrome characterized by massive lymphoid hyperplasia and extensive autoantibody production. Despite the similarities in disease progression, functional distinctions in these genetic defects have been observed in bone marrow transplantation studies. To elucidate the mechanisms responsible for the aberrant immune phenotype of these strains, we analyzed interactions between normal T cells and T cells from the two autoimmune strains with regard to their in vitro responses to autologous and allogeneic stimuli and in an in vivo bone marrow transplantation model. Despite similar propensities for lpr and gld T cells to spontaneously proliferate in vitro in response to autologous class II Ag, a dramatic difference in their immunoregulatory properties was found when mixtures of normal and autoimmune CD4+ responder cells were challenged with an allogeneic stimulus. T cells from the lpr, but not gld, mice blocked the normal T cell component of the response. In vivo, the ability of lpr stem cells to trigger a wasting syndrome when transplanted into normal irradiated recipients could not be prevented by including normal stem cells in the inoculum; however, the ability of gld stem cells to transfer the gld-lymphoproliferative syndrome to normal recipients could be prevented with the addition of normal stem cells. These results support a model whereby the lpr and gld strains are defective in reciprocal components of a down-regulatory signaling pathway; failure to express either the functional receptor or ligand leads to a dysregulated immune system resulting in systemic autoimmunity. Based on the linkage between the lpr locus and Fas Ag expression, we propose that the failure of lpr mice to express Fas results in overproduction of Fas-ligand, whereas gld mice fail to make either the Fas-ligand or a functionally related protein, presumably belonging to the TNF family.

Entities:  

Mesh:

Year:  1994        PMID: 8120369

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; C N Ellwood; N D Hall; D M Sansom
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 2.  Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.

Authors:  K Kajino; Y Kajino; M I Greene
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

3.  Induction of rapid T cell death and phagocytic activity by Fas-deficient lpr macrophages.

Authors:  Ritsuko Oura; Rieko Arakaki; Akiko Yamada; Yasusei Kudo; Eiji Tanaka; Yoshio Hayashi; Naozumi Ishimaru
Journal:  J Immunol       Date:  2012-12-19       Impact factor: 5.422

4.  A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.

Authors:  S Ono; D Shao; S Yamada; Y Yang; M Yamashita; T Hamaoka
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

5.  Development of grafted gld cells in athymic and euthymic recipients.

Authors:  N Rosenblatt; K U Hartmann; F Loor
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

6.  Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.

Authors:  Akio Matsuzawa; Motomu Shimizu; Yasutaka Takeda; Hisashi Nagase; Kazutoshi Sayama; Mikio Kimura
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

7.  Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.

Authors:  D Z Shao; S Yamada; F Hirayama; H Hirano; S Ono; T Hamaoka
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

8.  Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.

Authors:  D Watanabe; T Suda; H Hashimoto; S Nagata
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

9.  Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.

Authors:  J L Chu; P Ramos; A Rosendorff; J Nikolić-Zugić; E Lacy; A Matsuzawa; K B Elkon
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.